作者
James R. Stone,Arezou Khosroshahi,Zhang Wen,Emanuel Della‐Torre,Kazuichi Okazaki,Yoshiya Tanaka,Matthias Löhr,N. Schleinitz,Lingli Dong,Hisanori Umehara,Marco Lanzillotta,Zachary S. Wallace,Mikaël Ebbo,George Webster,F Valle,Manu Nayar,Cory A. Perugino,Vinciane Rebours,Xinxin Dong,Yanping Wu,Qing Li,Nishi Rampal,Daniel Cimbora,Emma L. Culver
摘要
IgG4-related disease is a multiorgan, relapsing, fibroinflammatory, immune-mediated disorder with no approved therapy. Inebilizumab targets and depletes CD19+ B cells and may be effective for treating patients with IgG4-related disease.
寻道图强
爱静静
坚强的广山
带头大哥
柯西
iNk
yufanhui
HEIKU
cannon8
pluto
合适洋葱
海4015
我不爱池鱼
CH
Singularity
Phosphene
乐乐乐乐乐乐
嗯哼
InfoNinja
shinysparrow
皖公网安备34019202002308
